tm logo
SPEVIGO
Live/Registered
REGISTERED

on 17 Oct 2023

Last Applicant/ Owned by

Binger Strasse 173

Ingelheim

DE

55216

Serial Number

97278135 filed on 22nd Feb 2022

Registration Number

7197428 registered on 17th Oct 2023

in the Principal Register

Correspondent Address

Max Moskowitz

OSTROLENK FABER LLP

845 THIRD AVENUE, 17th Floor

NEW YORK, NY 10022

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SPEVIGO

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, ceRead More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases


First Use Date in General

01st Sep 2022

First Use Date in Commerce

01st Sep 2022

Specimens


SPEVIGO specimen

Mark Details


Serial Number

No 97278135

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TE/3974-948

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Oct 2023REGISTERED-PRINCIPAL REGISTER
17th Oct 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th Sep 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08th Sep 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02th Aug 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
02th Aug 2023STATEMENT OF USE PROCESSING COMPLETE
14th Jul 2023TEAS STATEMENT OF USE RECEIVED
14th Jul 2023USE AMENDMENT FILED
21st Feb 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
27th Dec 2022PUBLISHED FOR OPPOSITION